|
⚲
|
| Keyboard |
| Kenneth Harrison | |
|---|---|
| Firm | |
| Address | c/o Claris Biotherapeutics, Inc 299 Pavonia Avenue, 38 Jersey City, NJ 07302 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Claris Biotherapeutics Inc | 021-558173 | Director | 2.3 M of 2.3 M |
||
| Claris Biotherapeutics Inc | 021-540201 | Director | 3.3 M of 3.3 M |
||
| Claris Biotherapeutics Inc | 021-501855 | Director | 10.0 M of 10.0 M |
||
| Reneo Pharmaceuticals Inc | 021-383843 | Director | 47.4 M of 94.8 M |
||
| Edgewise Therapeutics Inc | 021-382855 | Director | 95.0 M of 95.0 M |
||
| Aristea Therapeutics Inc | 021-378342 | Director | 63.1 M of 63.1 M |
||
| Claris Biotherapeutics Inc | 021-365789 | Director | 44.5 M of 44.5 M |
||
| Edgewise Therapeutics Inc | 021-349663 | Director | 25.1 M of 50.1 M |
||